Evidence map›Paper›PMID 39258104›Full record

ArticleCureus2024

Hybrid Bladder Tumor: Urothelial Carcinoma With Squamous Cell Differentiation, Urothelial Sarcomatoid Carcinoma, and Concurrent Primary Mucinous Adenocarcinoma With Metastasis to the Penis.

Petar Antonov, Gabriela Raycheva, Georgi Ivanov, Atanas Ivanov, Petar Uchikov, Veselin Popov, Georgi Tzigarovski, Alexandar Timev, Zhanet Grudeva

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Petar AntonovDepartment of Urology and General Medicine, Medical University of Plovdiv, Plovdiv, BGR.
Gabriela RaychevaDepartment of Clinical Oncology, Medical University of Plovdiv, Plovdiv, BGR.
Georgi IvanovDepartment of General and Clinical Pathology, Medical University of Plovdiv, Plovdiv, BGR.
Atanas IvanovDepartment of Urology and General Medicine, Medical University of Plovdiv, Plovdiv, BGR.
Petar UchikovDepartment of Special Surgery, Medical University of Plovdiv, Plovdiv, BGR.
Veselin PopovDepartment of Clinical Oncology, Medical University of Plovdiv, Plovdiv, BGR.
Georgi TzigarovskiDepartment of Urology and General Medicine, Medical University of Plovdiv, Plovdiv, BGR.
Alexandar TimevDepartment of Urology, Medical University of Sofia, Sofia, BGR.
Zhanet GrudevaDepartment of Clinical Oncology, Medical University of Plovdiv, Plovdiv, BGR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most common histological variants of bladder cancer include urothelial, squamous, and adenocarcinoma. In high-grade, invasive urothelial carcinoma, divergent differentiation can be observed, including glandular, squamous, trophoblastic, and small-cell types. Urothelial sarcomatoid carcinoma is characteristic of advanced carcinomas and is considered a possible common end route for all epithelial carcinomas. Adenocarcinoma of the bladder refers exclusively to true glandular carcinomas. Hybrid tumors are extremely rare and consist of more than one tumor type within the total tumor mass. Penile metastases are extremely uncommon, and there are no reported cases of metastatic adenocarcinoma of the bladder in the literature.

Indexed as

bladder adenocarcinomahybrid bladder tumorlocal recurrence of bladder cancermuscle-invasive bladder cancerpenile metastasis

Identifiers

PMID39258104
PMCPMC11384649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.